Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Thrombophilia D019851 6 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Mouth, Edentulous D009066 1 associated lipids
Pelvic Pain D017699 7 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Uveitis, Anterior D014606 11 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Migraine without Aura D020326 1 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Leukostasis D018921 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Viremia D014766 4 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Bronchiectasis D001987 7 associated lipids
Anthrax D000881 1 associated lipids
Heart Injuries D006335 6 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Drolet AM et al. Platelet-activating factor induces Th17 cell differentiation. 2011 Mediators Inflamm. pmid:22013287
Janakiram NB et al. Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. 2011 Cancer Metastasis Rev. pmid:22015691
Verouti SN et al. PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with oxLDL and IL-1β effects. 2011 Atherosclerosis pmid:21920519
Yu Y et al. Homosecoiridoids from the flower buds of Lonicera japonica. 2011 J. Nat. Prod. pmid:21942812
Ajiro Y et al. Platelet-activating factor stimulates sodium-hydrogen exchange in ventricular myocytes. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21949111
Ma J et al. ATP: a mediator for HCl-induced TRPV1 activation in esophageal mucosa. 2011 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:21960521
Bragado MJ et al. Platelet-activating factor in Iberian pig spermatozoa: receptor expression and role as enhancer of the calcium-induced acrosome reaction. 2011 Reprod. Domest. Anim. pmid:22023717
Rastogi P et al. Urothelial cell platelet-activating factor production mediated by calcium-independent phospholipase A2γ. 2011 Urology pmid:21094990
Uriarte SM et al. Granule exocytosis contributes to priming and activation of the human neutrophil respiratory burst. 2011 J. Immunol. pmid:21642540
Frelinger AL et al. Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44. 2011 Thromb. Haemost. pmid:21713327
Byrne SN et al. The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. 2011 Am. J. Pathol. pmid:21703403
Semini G et al. Impact of alkylphospholipids on the gene expression profile of HaCaT cells. 2011 Pharmacogenet. Genomics pmid:21681147
Khan BQ and Kemp SF Pathophysiology of anaphylaxis. 2011 Curr Opin Allergy Clin Immunol pmid:21659865
Lacy P et al. Agonist activation of f-actin-mediated eosinophil shape change and mediator release is dependent on Rac2. 2011 Int. Arch. Allergy Immunol. pmid:21576984
Fragel-Madeira L et al. Platelet activating factor blocks interkinetic nuclear migration in retinal progenitors through an arrest of the cell cycle at the S/G2 transition. 2011 PLoS ONE pmid:21298035
Garland RC et al. Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury. 2011 FASEB J. pmid:21257713
Mushtaq N et al. Adhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matter. 2011 J. Allergy Clin. Immunol. pmid:21247619
Singh TP et al. Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice. 2011 Am. J. Pathol. pmid:21281802
Metz M and Maurer M Rupatadine for the treatment of allergic rhinitis and urticaria. 2011 Expert Rev Clin Immunol pmid:21162645
Cureton EL et al. Endothelin-1 attenuates increases in hydraulic conductivity due to platelet-activating factor via prostacyclin release. 2011 J. Appl. Physiol. pmid:21183623
Liu J et al. Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase. 2011 Circ. Res. pmid:21183738
Saihkay HN et al. Validating 123I-metaiodobenzylguanidine as a platelet marker for non-invasive imaging in rabbits. 2011 Jan-Feb J Pharmacol Toxicol Methods pmid:20646985
Cingi C et al. The histopathological effect of thymoquinone on experimentally induced rhinosinusitis in rats. 2011 Nov-Dec Am J Rhinol Allergy pmid:22185737
Chini M et al. Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimen. 2012 AIDS Res. Hum. Retroviruses pmid:22050695
Nordin N et al. Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum. 2012 Pharm Biol pmid:22103812
Samapati R et al. Lung endothelial Ca2+ and permeability response to platelet-activating factor is mediated by acid sphingomyelinase and transient receptor potential classical 6. 2012 Am. J. Respir. Crit. Care Med. pmid:22246702
Yao Y et al. Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity. 2012 J. Biol. Chem. pmid:22303003
Du Y et al. Macrophage VLDL receptor promotes PAFAH secretion in mother's milk and suppresses systemic inflammation in nursing neonates. 2012 Nat Commun pmid:22910354
Jalil J et al. Platelet-activating factor (PAF) antagonistic activity of a new biflavonoid from Garcinia nervosa var. pubescens King. 2012 Molecules pmid:22964504
Kakazu A et al. Lipoxin Aâ‚„ inhibits platelet-activating factor inflammatory response and stimulates corneal wound healing of injuries that compromise the stroma. 2012 Exp. Eye Res. pmid:22828048
Uomo G Lesson from acute experimental pancreatitis: multidrug strategies is effective than single-target therapy. 2012 JOP pmid:22964964
Huang LG et al. [Effects of glycomacropeptide on damage to intestinal tissue and apoptosis of intestinal epithelial cells in neonatal rats with necrotizing enterocolitis]. 2012 Zhonghua Er Ke Za Zhi pmid:22932017
Pawlowic MC and Zhang K Leishmania parasites possess a platelet-activating factor acetylhydrolase important for virulence. 2012 Mol. Biochem. Parasitol. pmid:22954769
Nitoda E et al. Ocular actions of platelet-activating factor: clinical implications. 2012 Expert Opin. Ther. Targets pmid:22924390
Sahu RP et al. Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis. 2012 Carcinogenesis pmid:22223848
Iyú D et al. The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function. 2012 Thromb. Haemost. pmid:22318645
Xu LF et al. Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor. 2012 Inflammation pmid:21452036
Bai J et al. Sesquiterpenes from the roots of Illicium dunnianum. 2012 Phytochemistry pmid:22695122
Carosati E et al. 1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 2): action in other targets and antitargets. 2012 Curr. Med. Chem. pmid:22709009
Harpavat S et al. Novel treatments for NEC: keeping IBD in mind. 2012 Curr Gastroenterol Rep pmid:22623180
Flasiński M et al. Behavior of platelet activating factor in membrane-mimicking environment. Langmuir monolayer study complemented with grazing incidence X-ray diffraction and Brewster angle microscopy. 2012 J Phys Chem B pmid:22834697
Yuan D and He P Vascular remodeling alters adhesion protein and cytoskeleton reactions to inflammatory stimuli resulting in enhanced permeability increases in rat venules. 2012 J. Appl. Physiol. pmid:22837164
Gorman S and Hart PH The current state of play of rodent models to study the role of vitamin D in UV-induced immunomodulation. 2012 Photochem. Photobiol. Sci. pmid:22898802
Zhang XT et al. [Study on the pharmacokinetics of ginkgolide B for injection in rats]. 2012 Zhong Yao Cai pmid:22876684
Flamm MH et al. Multiscale prediction of patient-specific platelet function under flow. 2012 Blood pmid:22517902
Zhang XT et al. [Study on pharmacokinetics of ginkgolide B injection in Beagle dogs]. 2012 Zhong Yao Cai pmid:23213741
Mirpuri J et al. Lactobacillus rhamnosus (LGG) regulates IL-10 signaling in the developing murine colon through upregulation of the IL-10R2 receptor subunit. 2012 PLoS ONE pmid:23272193
Juchem G et al. Regulation of coronary venular barrier function by blood borne inflammatory mediators and pharmacological tools: insights from novel microvascular wall models. 2012 Am. J. Physiol. Heart Circ. Physiol. pmid:22081707
Saadawi S et al. Inhibitory effects of acetylmelodorinol, chrysin and polycarpol from Mitrella kentii on prostaglandin Eâ‚‚ and Thromboxane Bâ‚‚ production and platelet activating factor receptor binding. 2012 Molecules pmid:22538486
Oh SF et al. Resolvin E2 formation and impact in inflammation resolution. 2012 J. Immunol. pmid:22450811